AA
ACHV icon

Ancora Advisors’s Achieve Life Sciences ACHV Stock Holding History

Ancora Advisors’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-23
Closed -$51K – 526
2016
Q2 		$51K Sell
23
-11
-32% -$23K 0.01% 506
2016
Q1 		$52K Buy
+34
New +$55.4K 0.01% 484

Other funds holding ACHV

PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $403M AUM 43.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ancora Advisors's ACHV Position: Q3 2016 in Review

Ancora Advisors sold out of Achieve Life Sciences (ACHV) in Q3 2016, closing a stake of 23 shares — an estimated $51K sold.

Ancora Advisors first reported a position in ACHV in Q1 2016 and held it in 2 quarters. The position peaked at $52K in Q1 2016. 29 funds tracked by Wall St. Rank hold ACHV as of Q3 2016.

  • Ancora Advisors reported no remaining Achieve Life Sciences position as of Q3 2016 after selling out during the quarter.
  • Ancora Advisors sold 23 Achieve Life Sciences shares in Q3 2016, an estimated $51K.
  • Ancora Advisors first reported a position in Achieve Life Sciences in Q1 2016 and held it in 2 quarters.
  • Ancora Advisors's Achieve Life Sciences position peaked at $52K in Q1 2016.
  • 29 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2016.

Based on Ancora Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.